These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7242318)

  • 21. [Vasodilator therapy in congestive heart failure--hemodynamic effects of oral administered isosorbide dinitrate (author's transl)].
    Osamura Y; Takahashi S; Nakai K; Kimata S; Ogawa T; Hirosawa K
    Kokyu To Junkan; 1978 Jul; 26(7):677-83. PubMed ID: 674893
    [No Abstract]   [Full Text] [Related]  

  • 22. Isosorbide 5-mononitrate in the treatment of left ventricular failure following acute myocardial infarction.
    Murray RG; Gammage MD
    Cardiology; 1987; 74 Suppl 1():58-9. PubMed ID: 3607805
    [No Abstract]   [Full Text] [Related]  

  • 23. [Isosorbide mononitrate or dinitrate in coronary disease?].
    Schanzenbächer P; Kochsiek K
    Dtsch Med Wochenschr; 1983 May; 108(21):807-9. PubMed ID: 6851870
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hemodynamic effects of isosorbide-5-mononitrate at rest and during exertion in patients with serious angina pectoris].
    Biamino G; Oeff M; Andresen D; Lichey HJ; Prokein E; Arntz R; von Leitner E; Schröder R
    Med Welt; 1981 Apr; 32(14A):535-9. PubMed ID: 7242316
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term effect of isosorbide dinitrate and nifedipine, singly and in association, in patients with chronic heart failure.
    Jezek V; Jezková J; Michaljanic A; Niederle P; Feuereisl R
    Eur Heart J; 1990 Dec; 11(12):1059-64. PubMed ID: 2292252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hemodynamic and isotope study of the effects of sublingual and oral administration of isosorbide dinitrate in cardiac insufficiency].
    Chiche P; Baligadoo S
    Coeur Med Interne; 1976; 15(3):361-77. PubMed ID: 791567
    [No Abstract]   [Full Text] [Related]  

  • 27. [The duration of th effect of isosorbide-5-mononitrate--a new anti-anginal agent].
    Kozák P
    Vnitr Lek; 1985 Dec; 31(12):1217-21. PubMed ID: 4090311
    [No Abstract]   [Full Text] [Related]  

  • 28. Calcium channel blocker and isosorbide 5-mononitrate in the management of chronic cardiac failure.
    Hutton I; McGhie AI; Martin W; Tweddel AC
    Cardiology; 1987; 74 Suppl 1():72-5. PubMed ID: 3607808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effectiveness of the delayed-action form of isosorbide 5-mononitrate in ischemic heart disease].
    Hůla J; Trhlíková M
    Vnitr Lek; 1991 Mar; 37(3):248-54. PubMed ID: 2031313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Vasodilator agents in the therapeutic arsenal of cardiac insufficiency].
    Lavitola Pde L; Higa SS
    Rev Paul Med; 1986; 104(3):136-40. PubMed ID: 3563266
    [No Abstract]   [Full Text] [Related]  

  • 31. Vasodilator therapy in mitral regurgitation with chronic heart failure.
    Ghose JC; Burdhan A; Dasgupta A; Chhetri MK
    J Assoc Physicians India; 1978 Apr; 26(4):263-8. PubMed ID: 730700
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical evaluation of the changes produced by nitrates in patients with chronic heart insufficiency].
    Almenar L; Gimeno JV; Sotillo J; Moreno MT; Salvador A; Miró V; Mora V; Martínez Dolz L; Algarra F
    Rev Esp Cardiol; 1993 May; 46(5):298-303. PubMed ID: 8516538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
    Mahgoub AA; El-Medany AH; Abdulatif AS
    Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemodynamic effects of intravenous isosorbide dinitrate in patients of cardiac failure following acute myocardial infarction.
    Pande AK; Ambardekar SS; Kumar A; Tulpule AT; Goyal BK
    Indian Heart J; 1985; 37(6):339-42. PubMed ID: 3836934
    [No Abstract]   [Full Text] [Related]  

  • 35. [Orally active vasodilators in the management of chronic treatment-resistant cardiac failure (author's transl)].
    Wirtzfeld A; Klein G; Himmler FC; Schmidt G; Kutschera I; Sauer E
    Dtsch Med Wochenschr; 1980 Oct; 105(40):1379-83. PubMed ID: 7449633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of isosorbide nitrate, isosorbide-2- and 5-mononitrate on the exertion ECG and on the hemodynamics during atrial stimulation in patients with angina pectoris].
    Stauch M; Grewe N
    Z Kardiol; 1979 Oct; 68(10):687-93. PubMed ID: 516844
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hemodynamic effects of combined isosorbide dinitrate-nifedipine therapy in congestive heart failure (author's transl)].
    Matsui S; Murakami E; Takekoshi N; Murakami H; Masuya K; Nomura M; Fujita S; Tsuji S; Chadani T
    Kokyu To Junkan; 1981 Sep; 29(9):965-70. PubMed ID: 7323483
    [No Abstract]   [Full Text] [Related]  

  • 38. Nitrate therapy for congestive heart failure.
    Franciosa JA; Nordstrom LA; Cohn JN
    JAMA; 1978 Aug; 240(5):443-6. PubMed ID: 351232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic effects of isosorbide-5-mononitrate in acute and chronic treatment of coronary heart disease.
    Schuster P; Trieb G; Wiechmann HW
    Z Kardiol; 1983; 72 Suppl 3():251-4. PubMed ID: 6666229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Not just effective against symptoms of ischemia. Nitrates also improve prognosis].
    MMW Fortschr Med; 2002 Dec; 144(50):65. PubMed ID: 14610875
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.